In Investing

Acceleration of RAD204 Phase 1 dose escalation trial

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

Author

We appreciate you signing up! You’re now part of our community and will be the first to receive our latest updates, exclusive offers, and special content. Stay tuned for exciting news and insights straight to your inbox.
Your name

Your email
By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Popular News
- In Investing
  Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee
  May 12, 2025 No Comments
- In Investing
  Triumph Gold Discovers a New Silver and Gold Vein Showing at the Freegold Mountain Project, Yukon
  May 12, 2025 No Comments

Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee